Uike N, Suehiro Y, Takahira H, Shimada Y, Nagatoshi Y, Ikuno Y, Okamura J, Tasaka H, Miyamura T, Ishikura H
Department of Hematology, National Kyushu Cancer Center Hospital.
Rinsho Ketsueki. 1994 Aug;35(8):801-3.
We report a 42-year-old woman with acute lymphoblastic leukemia who received allogeneic bone marrow transplantation (BMT) in the first remission from her 75-year-old, HLA-identical, MLC-non-reactive mother. Considering the difficulty to obtain a sufficient number of bone marrow cells from such an old donor, we harvested the cells (2.31 x 10(8)/kg) on day -37 and cryopreserved them until use. BMT was performed on June 3rd, 1993 after conditioning regimen with total body irradiation, high-dose AraC and cyclophosphamide. Graft-versus-host disease (GVHD) prophylaxisis was attempted by cyclosporin A and short-term methtrexate. Her hematopoietic recovery was favorable with no signs and symptoms of GVHD as far as day 218.
我们报告了一名42岁的急性淋巴细胞白血病女性患者,她在首次缓解期接受了来自其75岁、HLA配型相同、混合淋巴细胞培养无反应的母亲的异基因骨髓移植(BMT)。考虑到从如此高龄的供体获取足够数量骨髓细胞存在困难,我们在移植前第37天采集了细胞(2.31×10⁸/kg)并冷冻保存直至使用。1993年6月3日,在进行全身照射、大剂量阿糖胞苷和环磷酰胺预处理后进行了BMT。尝试使用环孢素A和短期甲氨蝶呤预防移植物抗宿主病(GVHD)。直到第218天,她的造血恢复良好,没有GVHD的体征和症状。